A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Multicenter open study with docetaxel. Treatment of patients with locally advanced or metastatic breast carcinoma
Estudo aberto multicêntrico com docetaxel. Tratamento de doentes com carcinoma da mama localmente avançado ou metastático
Acta Médica Portuguesa
Estudo aberto multicêntrico com docetaxel. Tratamento de doentes com carcinoma da mama localmente avançado ou metastático
Preserved Fulltext
The efficacy and safety of docetaxel were evaluated in an open, multicentric, non comparative study involving 24 patients with locally advanced or metastatic breast cancer, eligible for second line or subsequent anticancer chemotherapy; the results confirm a global response around 50%, suggesting some advantages when compared to the usual treatments in this set of patients; the median duration of response, the median time to progression and the median time of survival were respectively, 309,
pmid:11762177
fatcat:pthvt4rrungnjhacw6ygxrefhq